92.27 MEUR
2.64 BEUR
219.78 M
About SYNLAB AG
Sector
Industry
CEO
Mathieu Olivier Floreani
Website
Headquarters
Munich
Employees (FY)
27.05 K
Founded
2019
FIGI
BBG01JY98SD6
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The firm offers medical diagnostic information for patients, practicing doctors, clinics, and the pharmaceutical industry. It operates through the following geographical segments: France, Germany, South Region, and North and East Regions. The company was founded by Bartholomaeus Wimmer in 1998 and is headquartered in Munich, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SYA is 10.00 EUR — it has increased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange SYNLAB AG stocks are traded under the ticker SYA.
SYA stock is 0.50% volatile and has beta coefficient of −0.25. Check out the list of the most volatile stocks — is SYNLAB AG there?
Yes, you can track SYNLAB AG financials in yearly and quarterly reports right on TradingView.
SYA net income for the last quarter is −77.18 M EUR, while the quarter before that showed 129.47 M EUR of net income which accounts for −159.61% change. Track more SYNLAB AG financial stats to get the full picture.
Today SYNLAB AG has the market capitalization of 2.20 B, it has increased by 0.93% over the last week.
No, SYA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SYA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNLAB AG stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 27.05 K employees. See our rating of the largest employees — is SYNLAB AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNLAB AG technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNLAB AG stock shows the neutral signal. See more of SYNLAB AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNLAB AG EBITDA is 422.77 M EUR, and current EBITDA margin is 15.61%. See more stats in SYNLAB AG financial statements.